Akebia Therapeutics Stock (NASDAQ: AKBA) stock price, news, charts, stock research, profile.
Open | $0.94 |
Close | $0.94 |
Volume / Avg. | 1.78M / 3.49M |
Day Range | 0.91 - 0.95 |
52 Wk Range | 0.78 - 2.48 |
Market Cap | $193.58M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 5.93% |
Days to Cover | 6.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Other companies in Akebia Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), Skye Bioscience (NASDAQ:SKYE), bluebird bio (NASDAQ:BLUE) and Inovio Pharmaceuticals (NASDAQ:INO).
There is no analysis for Akebia Therapeutics.
Akebia Therapeutics has a consensus price target of $4.00.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $0.9236 last updated July 5, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Akebia Therapeutics.
Akebia Therapeutics’s Q2 earnings are confirmed for Friday, August 23, 2024.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.